Gemfibrozil vs fenofibrate in treating hyperlipidemia
Bi Chen, Shu Chen
Abstract
Bi Chen, Shu Chen
Abstract
In 210 patients with hyperlipemia,109 patients(M60,F49;age 58±s 8 a) were treated with gemfibrozil 600 mg,po,bid×12 wk,and 101 patients(M66,F35;age 59±8a) were treated with fenofibrate 100 mg,po,bid×12 wk.Results shwed that in gemfibrozil group the levels of triglyceride(TG) and total cholesterol(TC) decreased 53.0%and 19.4% respectively, and high density lipoprotein cholesterol(HDL-ch) increased 26.8%(all P0.01).In fenofibrate group,the levels of TG and TC decreased 41.0% and 22.0%respectively and HDL-ch increased 22.0% (all P0.01).But the difference between the two groups was non significant (P0.05).No serious side effects were found during the therapeutic period,but 4 patients in gemfibrozil group and 5 patients in fenofibrate group had transient increase of GPT activity.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In 210 patients with hyperlipemia,109 patients(M60,F49;age 58±s 8 a) were treated with gemfibrozil 600 mg,po,bid×12 wk,and 101 patients(M66,F35;age 59±8a) were treated with fenofibrate 100 mg,po,bid×12 wk.Results shwed that in gemfibrozil group the levels of triglyceride(TG) and total cholesterol(TC) decreased 53.0%and 19.4% respectively, and high density lipoprotein cholesterol(HDL-ch) increased 26.8%(all P0.01).In fenofibrate group,the levels of TG and TC decreased 41.0% and 22.0%respectively and HDL-ch increased 22.0% (all P0.01).But the difference between the two groups was non significant (P0.05).No serious side effects were found during the therapeutic period,but 4 patients in gemfibrozil group and 5 patients in fenofibrate group had transient increase of GPT activity.
Key concepts: Gemfibrozil, Fenofibrate, Internal medicine, Hyperlipidemia, Triglyceride, Endocrinology, Cholesterol, Medicine